Abstract
We sought to evaluate the mortality, risk factors for mortality, and resource utilization following cardiac interventions in trisomy 13 (T13) and 18 (T18) children. All T13 and T18 children who underwent a cardiac intervention from January 1999 to March 2015 were identified from the Pediatric Health Information System database. Data collected included demographics, type of congenital heart disease (CHD), cardiac interventions, comorbidities, length of stay (LOS), hospital charges, and deaths (within 30 days). Logistic regression analysis was used to determine factors associated with mortality. There were 49 (47% females) T13 and 140 (67% females) T18 subjects. The two cohorts were similar in distribution for race, geographic region, insurance type, and median household income. The most common CHD in both groups was a shunt lesion followed by conotruncal defects. Compared to T18, the T13 cohort had higher mortality (29% vs. 12%), tracheostomies (12% vs. 4%), gastrostomies (18% vs. 6%), and overall resource use (P < 0.05 for all). White race (OR 0.23, 95% CI 0.06–0.81) in T13 and older age (in weeks) at surgery in T18 (OR 0.75, 95% CI 0.64–0.86) were associated with lower mortality. A select group of T13 and T18 CHD patients can undergo successful cardiac interventions, albeit with a higher mortality and resource use. T13 patients have higher mortality and resource use compared to T18. In T13 and T18 patients, interventions for CHD may be an acceptable and ethical option following a careful individualized selection and counseling by a team of experts.
Similar content being viewed by others
Abbreviations
- T13:
-
Trisomy 13
- T18:
-
Trisomy 18
- CHD:
-
Congenital heart disease
- LOS:
-
Length of stay
- PHIS:
-
Pediatric Health Information Systems
- RACHS:
-
Risk Adjustment for Congenital Heart Surgery
References
Rasmussen SA, Wong L-YC, Yang Q, May KM, Friedman JM (2003) Population-based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics 111(4):777–784
Baty B, Blackburn B, Carey J (1994) Natural history trisomy 18 and trisomy 13: growth, physical assessment, medical histories, survival, and recurrence risk. Am J Med Genet 49:175–188
Cereda A, Carey JC (2012) The trisomy 18 syndrome. Orphanet J Rare Dis 7(1):81
Wyllie J, Wright M, Burn J, Hunter S (1994) Natural history of trisomy 13. Arch Dis Child 71:343–345
Lin HY, Lin SP, Chen YJ et al (2006) Clinical characteristics and survival of trisomy 18 in a medical center in Taipei, 1988–2004. Am J Med Genet 140:945-951
Van Praagh S, Truman T, Firpo A et al (1989) Cardiac malformations in trisomy-18: a study of 41 postmortem cases. J Am Coll Cardiol 13(7):1586–1597
Yamagishi H (2010) Cardiovascular surgery for congenital heart disease associated with trisomy 18. Gen Thorac Cardiovasc Surg 58(5):217–219
Root S, Carey J (1994) Survival trisomy 18. Am J Med Genet 49:170–174
Nelson KE, Rosella LC, Mahant S, Guttmann A (2016) Survival and surgical interventions for children with trisomy 13 and 18. J Am Med Assoc 316(4):420–428
Meyer RE, Liu G, Gilboa SM et al (2016) Survival of children with trisomy 13 and trisomy 18: a multi-state population-based study. Am J Med Genet Part A 170(4):825–837
Kosho T, Nakamura T, Kawame H, Baba A, Tamura M, Fukushima Y (2006) Neonatal management of trisomy 18: Clinical details of 24 patients receiving intensive treatment. Am J Med Genet 140(9):937–944
Baty BJ, Jorde LB, Blackburn BL, Carey JC (1994) Natural history of trisomy 18 and trisomy 13: 11. Psychomotor Development. Am J Med Genet 49:189–194
Bruns DA (2015) Developmental status of 22 children with trisomy 18 and eight children with trisomy 13: implications and recommendations. Am J Med Genet Part A 167(8):1807–1815
Embleton ND, Wyllie JP, Wright MJ, Burn J, Hunter S (1996) Natural history of trisomy 18. Arch Dis Child Fetal Neonatal Ed 75(1):F38–F41
Kosho T (2008) Care of children with trisomy 18 in Japan. Am J Med Genet Part A 146:1369–1371
Mcgraw MP, Perlman JM (2008) Attitudes of neonatologists toward delivery room management of confirmed trisomy 18: potential factors influencing a changing dynamic what’s known on this subject. Pediatrics 121:1106–1110
Kobayashi J, Kaneko Y, Yamamoto Y, Yoda H, Tsuchiya K (2010) Radical surgery for a ventricular septal defect associated with trisomy 18. Gen Thorac Cardiovasc Surg 58(5):223–227
Kosiv KA, Gossett JM, Bai S, Collins RT (2017) Congenital heart surgery on in-hospital mortality in trisomy 13 and 18. Pediatrics 140(5):e20170772
Graham EM, Bradley SM, Shirali GS, Hills CB, Atz AM (2004) Effectiveness of cardiac surgery in trisomies 13 and 18 (from the Pediatric Cardiac Care Consortium). Am J Cardiol 93(6):801–803
Costello JP, Weiderhold A, Clauden L et al (2015) A contemporary, single-institutional experience of surgical versus expectant management of congenital heart disease in trisomy 13 and 18 patients. Pediatr Cardiol 36:987–992
Maeda J, Yamagishi H, Furutani Y et al (2011) The impact of cardiac surgery in patients with trisomy 18 and trisomy 13 in Japan. Am J Med Genet 155:2641–2646
Muneuchi J, Yamamoto J, Takahashi Y et al (2011) Outcomes of cardiac surgery in trisomy 18 patients. Cardiol Young 21:209–215
Kaneko Y, Kobayashi J, Yamamoto Y et al (2008) Intensive cardiac management in patients with trisomy 13 or trisomy 18. Am J Med Genet Part A 146:1372–1380
Josephsen JB, Armbrecht ES, Braddock SR, Cibulskis CC (2016) Procedures in the 1st year of life for children with trisomy 13 and trisomy 18, a 25-year, single-center review. Am J Med Genet Part C 172:264–271
Donovan JH, Krigbaum G, Bruns DA (2016) Medical interventions and survival by gender of children with trisomy 18. Am J Med Genet Part C172:272–278
Kaneko Y, Kobayashi J, Achiwa I et al (2009) Cardiac surgery in patients with trisomy 18. Pediatr Cardiol 30:729–734
Yates A, Hoffman T, Shepherd E, Boettner B, McBride K (2011) Pediatric subspecialist controversies in the treatment of congenital heart disease in trisomy 13 or trisomy 18. J Genet Couns 20:495–509
Feudtner C, Hays RM, Haynes G, Geyer JR, Neff JM, Koepsell TD (2001) Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services. Pediatrics 107(6):e99–e99
Peterson JK, Kochilas LK, Catton KG, Moller JH, Setty SP (2017) Long-term outcomes of children with trisomy 13 and 18 after congenital heart disease interventions. Ann Thorac Surg 103(6):1941–1949
Nelson K, Hexem K, Feudtner C (2012) Inpatient hospital care of children with trisomy 13 and trisomy 18 in the United States. Pediatrics 128(5):869–876
Musewe NN, Alexander DJ, Teshima I, Smallhorn JF, Freedom RM (1990) Echocardiographic evaluation of the spectrum of cardiac anomalies associated with trisomy 13 and trisomy 18. J Am Coll Cardiol 15(3):673–677
Vendola C, Canfield M, Daiger SP et al (2010) Survival of Texas infants born with trisomies 21, 18, and 13. Am J Med Genet Part A 152(2):360–366
Jacobs JP, Mayer JE, Mavroudis C et al (2017) The Society of Thoracic Surgeons congenital heart surgery database: 2017 update on outcomes and quality. Ann Thorac Surg 103(3):699–709
Pasquali SK, He X, Jacobs ML et al (2014) Excess costs associated with complications and prolonged length of stay after congenital heart surgery. Ann Thorac Surg 98(5):1660–1666
Dereddy NR, Pivnick EK, Upadhyay K, Dhanireddy R, Talati AJ (2017) Neonatal hospital course and outcomes of live-born infants with trisomy 18 at two tertiary care centers in the United States. Am J Perinatol 34(3):270–275
Carey JC (2010) Trisomy 18 and trisomy 13 syndromes. In: Management of genetic syndromes. 3rd Ed. pp 807–823
Janvier A, Farlow B, Barrington KJ (2016) Parental hopes, interventions, and survival of neonates with trisomy 13 and trisomy 18. Am J Med Genet Part C Semin Med Genet 172(3):279–287
Bruns DA, Martinez A (2016) An analysis of cardiac defects and surgical interventions in 84 cases with full trisomy 18. Am J Med Genet Part A 170(2):337–343
Kosho T, Kuniba H, Tanikawa Y, Hashimoto Y, Sakurai H (2013) Natural history and parental experience of children with trisomy 18 based on a questionnaire given to a Japanese trisomy 18 parental support group. Am J Med Genet Part A 161(7):1531–1542
Andrews SE, Downey AG, Showalter DS et al (2016) Shared decision making and the pathways approach in the prenatal and postnatal management of the trisomy 13 and trisomy 18 syndromes. Am J Med Genet Part C Semin Med Genet 172(3):257–263
Funding
No funding was received for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Dr. John C. Carey is a medical adviser for the Support Organization for Trisomy 18, 13, and Related Disorders (SOFT organization). All other authors declare that they have no conflicts of interest.
Ethical Approval and Informed Consent
.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.
Rights and permissions
About this article
Cite this article
Domingo, L., Carey, J.C., Eckhauser, A. et al. Mortality and Resource Use Following Cardiac Interventions in Children with Trisomy 13 and Trisomy 18 and Congenital Heart Disease. Pediatr Cardiol 40, 349–356 (2019). https://doi.org/10.1007/s00246-018-2001-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-018-2001-x